Report Detail

Pharma & Healthcare Global Ropivacaine Market Status and Forecast 2021-2027

  • RnM4334412
  • |
  • 20 July, 2021
  • |
  • Global
  • |
  • 178 Pages
  • |
  • GRD Survey
  • |
  • Pharma & Healthcare

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Ropivacaine Market Status and Forecast (2016-2027)
      • 1.3.2 Global Ropivacaine Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Ropivacaine Supply by Company

    • 2.1 Global Ropivacaine Sales Volume by Company
    • 2.2 Global Ropivacaine Sales Value by Company
    • 2.3 Global Ropivacaine Price by Company
    • 2.4 Ropivacaine Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Ropivacaine Market Status by Type

    • 3.1 Ropivacaine Type Introduction
      • 3.1.1 Lumbar Epidural Administration
      • 3.1.2 Thoracic Epidural Administration
      • 3.1.3 Regional Block
    • 3.2 Global Ropivacaine Market by Type
      • 3.2.1 Global Ropivacaine Sales Volume by Type (2016-2021)
      • 3.2.2 Global Ropivacaine Sales Value by Type (2016-2021)
      • 3.2.3 Global Ropivacaine Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Ropivacaine Market Status by Application

    • 4.1 Ropivacaine Segment by Application
      • 4.1.1 Anesthesia
      • 4.1.2 Systemic Neuropathic Pain
      • 4.1.3 Postherpes Pain
      • 4.1.4 Post-Operative Pain
      • 4.1.5 Surgical Analgesia
      • 4.1.6 Labor Analgesia
      • 4.1.7 Other
    • 4.2 Global Ropivacaine Market by Application
      • 4.2.1 Global Ropivacaine Sales Volume by Application (2016-2021)
      • 4.2.2 Global Ropivacaine Sales Value by Application (2016-2021)
      • 4.2.3 Global Ropivacaine Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Ropivacaine Market Status by Region

    • 5.1 Global Ropivacaine Market by Region
      • 5.1.1 Global Ropivacaine Sales Volume by Region
      • 5.1.2 Global Ropivacaine Sales Value by Region
    • 5.2 North America Ropivacaine Market Status
    • 5.3 Europe Ropivacaine Market Status
    • 5.4 Asia Pacific Ropivacaine Market Status
    • 5.5 Central & South America Ropivacaine Market Status
    • 5.6 Middle East & Africa Ropivacaine Market Status

    6 North America Ropivacaine Market Status

    • 6.1 North America Ropivacaine Market by Country
      • 6.1.1 North America Ropivacaine Sales Volume by Country (2016-2021)
      • 6.1.2 North America Ropivacaine Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Ropivacaine Market Status

    • 7.1 Europe Ropivacaine Market by Country
      • 7.1.1 Europe Ropivacaine Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Ropivacaine Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Ropivacaine Market Status

    • 8.1 Asia Pacific Ropivacaine Market by Country
      • 8.1.1 Asia Pacific Ropivacaine Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Ropivacaine Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Ropivacaine Market Status

    • 9.1 Central & South America Ropivacaine Market by Country
      • 9.1.1 Central & South America Ropivacaine Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Ropivacaine Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Ropivacaine Market Status

    • 10.1 Middle East & Africa Ropivacaine Market by Country
      • 10.1.1 Middle East & Africa Ropivacaine Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Ropivacaine Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Ropivacaine Manufacturing Cost Analysis
    • 11.5 Ropivacaine Sales Channel and Distributors Analysis
      • 11.5.1 Ropivacaine Sales Channel
      • 11.5.2 Ropivacaine Distributors
    • 11.6 Ropivacaine Downstream Major Buyers

    12 Global Ropivacaine Market Forecast by Type and by Application

    • 12.1 Global Ropivacaine Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Ropivacaine Forecast by Type
      • 12.2.1 Global Ropivacaine Sales Volume Forecast by Type
      • 12.2.2 Global Ropivacaine Sales Value Forecast by Type
      • 12.2.3 Global Ropivacaine Price Forecast by Type
    • 12.3 Global Ropivacaine Forecast by Application
      • 12.3.1 Global Ropivacaine Sales Volume Forecast by Application
      • 12.3.2 Global Ropivacaine Sales Value Forecast by Application
      • 12.3.3 Global Ropivacaine Price Forecast by Application

    13 Global Ropivacaine Market Forecast by Region/Country

    • 13.1 Global Ropivacaine Market Forecast by Region (2022-2027)
      • 13.1.1 Global Ropivacaine Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Ropivacaine Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Zhejiang Xianju Pharmaceutical
      • 14.1.1 Company Information
      • 14.1.2 Ropivacaine Product Introduction
      • 14.1.3 Zhejiang Xianju Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Yichang Renfu Pharmaceutical
      • 14.2.1 Company Information
      • 14.2.2 Ropivacaine Product Introduction
      • 14.2.3 Yichang Renfu Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Yangtze Pharmaceutical Group
      • 14.3.1 Company Information
      • 14.3.2 Ropivacaine Product Introduction
      • 14.3.3 Yangtze Pharmaceutical Group Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Xi'an Hanfeng Pharmaceutical
      • 14.4.1 Company Information
      • 14.4.2 Ropivacaine Product Introduction
      • 14.4.3 Xi'an Hanfeng Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Taiwan Liposome Company
      • 14.5.1 Company Information
      • 14.5.2 Ropivacaine Product Introduction
      • 14.5.3 Taiwan Liposome Company Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Shenyang Sansheng Pharmaceutical
      • 14.6.1 Company Information
      • 14.6.2 Ropivacaine Product Introduction
      • 14.6.3 Shenyang Sansheng Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 Shanxi Pude Pharmaceutical
      • 14.7.1 Company Information
      • 14.7.2 Ropivacaine Product Introduction
      • 14.7.3 Shanxi Pude Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Shandong New Era Pharmaceutical
      • 14.8.1 Company Information
      • 14.8.2 Ropivacaine Product Introduction
      • 14.8.3 Shandong New Era Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 Shaanxi Bosen Biopharmaceutical
      • 14.9.1 Company Information
      • 14.9.2 Ropivacaine Product Introduction
      • 14.9.3 Shaanxi Bosen Biopharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 Qilu Pharmaceutical
      • 14.10.1 Company Information
      • 14.10.2 Ropivacaine Product Introduction
      • 14.10.3 Qilu Pharmaceutical Ropivacaine Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 PainReform Ltd
    • 14.12 Nuvo Pharmaceuticals
    • 14.13 Jiangsu Hengrui Pharmaceutical
    • 14.14 Jiangsu Enhua Pharmaceutical
    • 14.15 Heron Therapeutics
    • 14.16 Hebei Yipin Pharmaceutical
    • 14.17 Hainan Sida Pharmaceutical
    • 14.18 Guangdong Jiabo Pharmaceutical
    • 14.19 Guangdong Huarun Shunfeng Pharmaceutical
    • 14.20 Encore Therapeutics
    • 14.21 Chenxin Pharmaceutical
    • 14.22 Chengdu Tiantaishan Pharmaceutical
    • 14.23 Celgene
    • 14.24 AstraZeneca
    • 14.25 Aspen Pharmacare
    • 14.26 Anhui Wellman Pharmaceutical

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Ropivacaine market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Ropivacaine industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to this survey, the global Ropivacaine market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Ropivacaine Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Ropivacaine market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Ropivacaine Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Ropivacaine industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      Lumbar Epidural Administration
      Thoracic Epidural Administration

      Segmented by Application
      Anesthesia
      Systemic Neuropathic Pain
      Postherpes Pain
      Post-Operative Pain
      Surgical Analgesia
      Labor Analgesia
      Other

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Yangtze Pharmaceutical Group
      Xi'an Hanfeng Pharmaceutical
      Taiwan Liposome Company
      Shenyang Sansheng Pharmaceutical
      Shanxi Pude Pharmaceutical
      Shandong New Era Pharmaceutical
      Shaanxi Bosen Biopharmaceutical
      Qilu Pharmaceutical
      PainReform Ltd
      Nuvo Pharmaceuticals
      Jiangsu Hengrui Pharmaceutical
      Jiangsu Enhua Pharmaceutical
      Heron Therapeutics
      Hebei Yipin Pharmaceutical
      Hainan Sida Pharmaceutical
      Guangdong Jiabo Pharmaceutical
      Guangdong Huarun Shunfeng Pharmaceutical
      Encore Therapeutics
      Chenxin Pharmaceutical
      Chengdu Tiantaishan Pharmaceutical
      Celgene
      AstraZeneca
      Aspen Pharmacare
      Anhui Wellman Pharmaceutical


      Summary:
      Get latest Market Research Reports on Ropivacaine. Industry analysis & Market Report on Ropivacaine is a syndicated market report, published as Global Ropivacaine Market Status and Forecast 2021-2027. It is complete Research Study and Industry Analysis of Ropivacaine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $2,980.00
      $4,470.00
      $5,960.00
      2,139.64
      3,209.46
      4,279.28
      2,506.18
      3,759.27
      5,012.36
      326,786.80
      490,180.20
      653,573.60
      221,533.20
      332,299.80
      443,066.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report